Flunarizine

Flunarizine is a selective calcium entry blocker used for the prophylactic treatment of migraine, vertigo, and peripheral vascular disease. It blocks voltage-dependent calcium channels and exhibits antihistaminic and dopamine D2 receptor blocking properties.

Mediocon Inc supplies Flunarizine IP/BP/USP as a pharmaceutical-grade API for manufacturers producing antimigraine and neurological formulations. With robust quality controls and GMP-certified manufacturing, we ensure consistent purity and efficacy in every batch.

Key Features

• Selective calcium channel blocker
• Antimigraine & antivertigo action
• Dopamine D2 antagonist activity
• Stable shelf life with proper storage

Applications

• Migraine prophylaxis tablets & capsules
• Vertigo treatment formulations
• Peripheral vascular disease therapy
• Neurological & CNS product manufacturing

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings